Clinical trial results of new therapies for HBV: Implications for treatment guidelines

Robert G. Gish

doi:10.1055/s-2005-915648

Clinical trial results of new therapies for HBV: Implications for treatment guidelines

Robert G. Gish

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	29-39
Number of pages	11
Journal	Seminars in Liver Disease
Volume	25
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1055/s-2005-915648
State	Published - 2005
Externally published	Yes

ASJC Scopus Subject Areas

Hepatology

Keywords

Entecavir
Hepatitis B
Nucleoside analogue
Pegylated interferon

Access to Document

10.1055/s-2005-915648

OpenUrl availability

Full text

Cite this

@article{e19185de61aa451181f1c886341231d3,

title = "Clinical trial results of new therapies for HBV: Implications for treatment guidelines",

keywords = "Entecavir, Hepatitis B, Nucleoside analogue, Pegylated interferon",

author = "Gish, \{Robert G.\}",

year = "2005",

doi = "10.1055/s-2005-915648",

language = "English",

volume = "25",

pages = "29--39",

journal = "Seminars in Liver Disease",

issn = "0272-8087",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Clinical trial results of new therapies for HBV

T2 - Implications for treatment guidelines

AU - Gish, Robert G.

PY - 2005

Y1 - 2005

KW - Entecavir

KW - Hepatitis B

KW - Nucleoside analogue

KW - Pegylated interferon

UR - https://www.scopus.com/pages/publications/24344436307

UR - https://www.scopus.com/pages/publications/24344436307#tab=citedBy

U2 - 10.1055/s-2005-915648

DO - 10.1055/s-2005-915648

M3 - Review article

C2 - 16103979

AN - SCOPUS:24344436307

SN - 0272-8087

VL - 25

SP - 29

EP - 39

JO - Seminars in Liver Disease

JF - Seminars in Liver Disease

IS - SUPPL. 1

ER -

Clinical trial results of new therapies for HBV: Implications for treatment guidelines

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this